ODM-207

CAS No. 1801503-93-4

ODM-207 ( BET-IN-4; ODM-207; ODM207 )

Catalog No. M26070 CAS No. 1801503-93-4

BET-IN-4 is a potent BRD4 inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 86 Get Quote
5MG 132 Get Quote
10MG 215 Get Quote
25MG 393 Get Quote
50MG 565 Get Quote
100MG 800 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    ODM-207
  • Note
    Research use only, not for human use.
  • Brief Description
    BET-IN-4 is a potent BRD4 inhibitor.
  • Description
    BET-IN-4 is a potent BRD4 inhibitor.(In Vitro):BET-IN-4 inhibits BRD4 with an IC50?of ≤ 1 μM.
  • Synonyms
    BET-IN-4; ODM-207; ODM207
  • Pathway
    Chromatin/Epigenetic
  • Target
    Epigenetic Reader Domain
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1801503-93-4
  • Formula Weight
    375.4
  • Molecular Formula
    C22H21N3O3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    COc1cc2n(Cc3ccccn3)c(=O)c(C)cc2cc1-c1c(C)noc1C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Kao-Lu Pan, et al. Identification of trans,trans-2,4-decadienal metabolites in mouse and human cells using liquid chromatography-mass spectrometry. Chem Res Toxicol. 2014 Oct 20;27(10):1707-19.
molnova catalog
related products
  • Y06137

    Y06137 is an effective and selective BET inhibitor with a Kd of 81 nM for BRD4(1) bromodomain. Y06137 can be used for research on the treatment of castration-resistant prostate cancer.

  • GSK778

    GSK778 is a potent and selective inhibitor of BD1 bromodomain such as BRD2 BD1 (IC50s = 75 nM), BRD3 BD1 (IC50s = 41 nM), BRD4 BD1 (IC50s = 41 nM), and BRDT BD1 (IC50s = 143 nM). GSK778 inhibits proliferation, induces a cell cycle arrest and apoptosis.

  • 3-methyl-1,2,3,4-tet...

    3-methyl-1,2,3,4-tetrahydroquinazolin-2-one is a inhibitor of BRD4 .